2016 - Neonatal Pharmacology

The Spectrum of Cytomegalovirus: Progress and Challenges! (Rx = .75 hr.) ACPE #0263-000-16-604-L01-P (.75 contact hr.)

Apr 14, 2016 2:15pm ‐ Apr 14, 2016 3:00pm

Expiration Date: May 5, 2019


Credits: None available.

Standard: $15.00

Description

Learning Objectives:

  • Know the clinical manifestations and sequelae of congenital CMV infection
  • Determine the optimal evaluation of neonates with congenital CMV infection
  • Describe the importance of early identification and optimal treatment of neonates with congenital CMV infection

Speaker(s):

Disclosures

  • Pablo Sanchez, MD:

    Abvie ; Consultant; Advisory Panel; Speaker

    Novartis ; Consultant

Credits

  • 0.75 - Pharmacology
  • 1.25 - Physician
  • 1.25 - RN / NP (All RNs/Nurses except CA RNs)
  • 1.25 - CA RN/CA BRN
  • 0.75 - Pharmacist

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content